XML 12 R2.htm IDEA: XBRL DOCUMENT v3.22.0.1
Consolidated Statements of Income - USD ($)
shares in Thousands
 3 Months Ended
Dec. 25, 2021
Dec. 26, 2020
Revenues:    
Product $ 1,303,300,000 $ 1,455,400,000
Service and other 167,800,000 154,400,000
Revenues 1,471,100,000 1,609,800,000
Costs of revenues:    
Product 318,100,000 284,500,000
Amortization, Cost of Goods Sold 74,900,000 61,600,000
Service and other 91,800,000 83,300,000
Gross profit 986,300,000 1,180,400,000
Operating expenses:    
Research and development 72,800,000 59,300,000
Selling and marketing 147,400,000 128,000,000.0
General and administrative 117,900,000 91,500,000
Amortization of acquired intangible assets 10,800,000 10,100,000
Contingent consideration fair value adjustments (4,100,000) 4,600,000
Restructuring and divestiture charges 200,000 1,400,000
Operating expenses 345,000,000.0 294,900,000
Income from operations 641,300,000 885,500,000
Interest income 500,000 400,000
Interest expense (25,700,000) (28,100,000)
Debt extinguishment losses (700,000) (21,600,000)
Other income (expense), net 6,500,000 (3,800,000)
Income before income taxes 621,900,000 832,400,000
Provision for income taxes 122,700,000 179,000,000.0
Net income 499,200,000 653,400,000
Net loss attributable to noncontrolling interest 0 (1,000,000.0)
Net income attributable to Hologic $ 499,200,000 $ 654,400,000
Net income per common share attributable to Hologic:    
Basic (in usd per share) $ 1.97 $ 2.53
Diluted (in usd per share) $ 1.95 $ 2.50
Weighted average number of shares outstanding:    
Basic (in shares) 253,499 258,605
Diluted (in shares) 256,070 261,785